NCT03301493 - Genomic Testing and Resulting Medical Decisions | Biotech Hunter

Enrollment

1,500

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

November 30, 2024

Conditions

Cancer of Unknown OriginCancer RefractoryCancer of StomachCancer Head NeckCancer of SkinCancer, LungCancer ColorectalCancer of EsophagusCancer, BladderCancer, UterusCancer CervixCancer LiverCancer, KidneyCancer, BreastHematologic Neoplasms

Interventions

OTHER

Genomic testing

Genomic profiling, indicated as assessed by the medical need and as deemed appropriate by the physician according to routine practice

Trial Locations (11)

1090

Medizinische Universität Wien, Vienna

3100

Universitätsklinikum St. Pölten, Sankt Pölten

4600

Klinikum Wels-Grieskirchen GmbH, Wels

4840

Salzkammergut-Klinikum Vöcklabruck, Vöcklabruck

5020

IIIrd Medical Department, Private Medical University Hospital Salzburg, Salzburg

6020

Medizinische Universität Innsbruck, Innsbruck

6500

Universitätsklinikum Krems, Krems

6511

St. Vinzenz Krankenhaus Betriebs GmbH, Zams

6807

Innere Medizin II, LKH Feldkirch, Feldkirch

A-8036

Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie, Graz

A-4020

BHS Linz: Interne I: Internistische Onkologie, Hämatologie und Gastroenterologie, Linz